| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
931 |
870 |
$1.30M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
5,561 |
5,032 |
$578K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,503 |
4,121 |
$243K |
| 92250 |
|
6,105 |
5,634 |
$232K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,718 |
3,370 |
$146K |
| 92134 |
|
5,932 |
5,400 |
$117K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,769 |
1,668 |
$114K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
429 |
393 |
$47K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
242 |
229 |
$26K |
| J9035 |
Injection, bevacizumab, 10 mg |
670 |
619 |
$26K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
18 |
18 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
47 |
46 |
$4K |
| 92015 |
Determination of refractive state |
2,442 |
2,299 |
$3K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
51 |
43 |
$3K |
| 92235 |
|
26 |
25 |
$1K |
| 92083 |
|
27 |
27 |
$986.82 |
| 92025 |
|
28 |
26 |
$515.80 |
| 92132 |
|
12 |
12 |
$313.94 |
| 92133 |
|
12 |
12 |
$303.06 |
| 99072 |
|
97 |
95 |
$26.28 |
| 99024 |
|
38 |
28 |
$0.00 |